CLYYF
Price
$0.65
Change
-$0.03 (-4.41%)
Updated
Feb 18 closing price
Capitalization
20.55M
HLVX
Price
$1.79
Change
-$0.05 (-2.72%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
89.4M
3 days until earnings call
Ad is loading...

CLYYF vs HLVX

Header iconCLYYF vs HLVX Comparison
Open Charts CLYYF vs HLVXBanner chart's image
Celyad Oncology SA
Price$0.65
Change-$0.03 (-4.41%)
Volume$500
Capitalization20.55M
HilleVax
Price$1.79
Change-$0.05 (-2.72%)
Volume$3.57K
Capitalization89.4M
CLYYF vs HLVX Comparison Chart
Loading...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLYYF vs. HLVX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLYYF is a Buy and HLVX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (CLYYF: $0.65 vs. HLVX: $1.84)
Brand notoriety: CLYYF and HLVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLYYF: 28% vs. HLVX: 34%
Market capitalization -- CLYYF: $20.55M vs. HLVX: $89.4M
CLYYF [@Biotechnology] is valued at $20.55M. HLVX’s [@Biotechnology] market capitalization is $89.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLYYF’s FA Score shows that 0 FA rating(s) are green whileHLVX’s FA Score has 1 green FA rating(s).

  • CLYYF’s FA Score: 0 green, 5 red.
  • HLVX’s FA Score: 1 green, 4 red.
According to our system of comparison, HLVX is a better buy in the long-term than CLYYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLVX’s TA Score shows that 5 TA indicator(s) are bullish.

  • HLVX’s TA Score: 5 bullish, 2 bearish.

Price Growth

CLYYF (@Biotechnology) experienced а 0.00% price change this week, while HLVX (@Biotechnology) price change was +2.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.84%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.37%.

Reported Earning Dates

HLVX is expected to report earnings on Jun 04, 2025.

Industries' Descriptions

@Biotechnology (+0.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLVX($89.4M) has a higher market cap than CLYYF($20.6M). CLYYF YTD gains are higher at: 165.306 vs. HLVX (-11.111).
CLYYFHLVXCLYYF / HLVX
Capitalization20.6M89.4M23%
EBITDAN/A-143.17M-
Gain YTD165.306-11.111-1,488%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A189M-
Total DebtN/A25M-
FUNDAMENTALS RATINGS
CLYYF: Fundamental Ratings
CLYYF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
31

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLVX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
79%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Ad is loading...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WTV83.641.09
+1.32%
WisdomTree US Value ETF
IOO100.360.89
+0.89%
iShares Global 100 ETF
MIG21.31-0.07
-0.33%
VanEck IG Corporate ETF
MVT10.68-0.09
-0.84%
Blackrock Munivest Fund II
UAE16.92-0.17
-0.99%
iShares MSCI UAE ETF

CLYYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYYF has been loosely correlated with ELVAF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYYF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYYF
1D Price
Change %
CLYYF100%
N/A
ELVAF - CLYYF
47%
Loosely correlated
N/A
REPL - CLYYF
35%
Loosely correlated
-1.96%
HLVX - CLYYF
29%
Poorly correlated
-2.13%
IBIO - CLYYF
23%
Poorly correlated
-8.94%
ATHE - CLYYF
22%
Poorly correlated
+4.20%
More

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been closely correlated with FBIOP. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if HLVX jumps, then FBIOP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
-2.13%
FBIOP - HLVX
83%
Closely correlated
+0.36%
BRIBF - HLVX
55%
Loosely correlated
N/A
PLRX - HLVX
37%
Loosely correlated
+2.53%
NTLA - HLVX
37%
Loosely correlated
+4.55%
SCPH - HLVX
33%
Loosely correlated
-6.09%
More